BC Biomedical News
Thursday, 20 February 2014 16:58
TORONTO, February 19, 2014 – LifeLabs Medical Laboratory Services (“LifeLabs”) announced today the acquisition of Centogene AG’s (‘Centogene’) Canadian business. Based in Germany, Centogene is a world leader in genetics testing for inherited diseases, with not only one of the world’s most extensive genetic test portfolios, but also one of the largest databases of genetic mutations for rare diseases. Centogene performs testing for a number of genetic centres across Canada.
This acquisition places LifeLabs in a leadership role in genetic testing in Canada. Genetic and genomic testing are the fastest growing segments in laboratory medicine and form the underlying basis for ‘personalized medicine’. With this acquisition, all of Centogene’s testing services will continue uninterrupted for Centogene’s Canadian clients. Over the coming months, Centogene’s test portfolio will be transitioned from Germany to LifeLabs’ laboratories in Canada, resulting in an improved level of service and faster turn-around times for Canadians.
“LifeLabs is committed to building a healthier Canada through the delivery of exceptional diagnostic testing, information and service. We are thrilled to partner with Centogene, an established and respected world leader in genetic testing and medical interpretation with a deep understanding of the Canadian marketplace,” said Sue Paish, President and CEO of LifeLabs. “Genetic testing is a significant element of the future of health care in Canada. LifeLabs will work with Centogene, health care providers, patients and other stakeholders so that Canadians benefit from this growing and exciting area in an effective and efficient way.”
In 2013, LifeLabs acquired BC Biomedical in British Columbia and CML HealthCare in Ontario making LifeLabs the largest community laboratory in Canada.
“The purchase of Centogene’s Canadian business is another demonstration of the commitment that LifeLabs has to health care in Canada,” said John Knowlton, LifeLabs Board Chair. “With this purchase, LifeLabs will now have the ability to provide Canadians with a broad menu of high-quality genetic tests to serve their health care needs.”
“This partnership brings together LifeLabs’ Canadian presence, reputation and extensive network of sample collection centres throughout Canada with Centogene’s worldwide experience in genetic diagnostics and result interpretation, supported by our unique mutation database,” said Michael Schlenk, CEO of Centogene. “Working together, we will be able to serve patients and providers in the best possible way - especially since both our companies share the same commitment to patient care, quality and innovation.”
LifeLabs is a Canadian-owned company and is the country's largest provider of community laboratory services with over 50 years of experience providing laboratory testing services to help health care providers diagnose, treat, monitor and prevent disease in patients. In communities across British Columbia and Ontario, LifeLabs delivers cost-effective, convenient access to laboratory testing services which are essential for optimal outcomes in health care. LifeLabs employs approximately 5,400 professionally trained staff and delivers over 100 million laboratory tests, serving 19 million patients annually. In 2013, LifeLabs acquired BC Biomedical in British Columbia and CML HealthCare in Ontario making LifeLabs the largest community laboratory in Canada. LifeLabs is indirectly owned by OMERS Administration Corporation, whose interest is managed by Borealis Infrastructure. For more information, please visit: www.LifeLabs.com.
About Borealis Infrastructure Management Inc.
Borealis is a leader in direct infrastructure investing with over a decade of investment experience. Borealis manages approximately CAD 10 billion in OMERS equity capital through investments in a diversified portfolio of large-scale infrastructure assets exhibiting stability and strong cash flows, in sectors including energy, transportation and government-regulated services. It has offices in Toronto, London and New York. Borealis is the infrastructure investment arm of OMERS. For more information please visit: www.borealis.ca.
OMERS is one of Canada's largest pension funds with over $60 billion in net assets. It provides first-class pension administration and innovative products and services to over 430,000 members. Approximately one in every 20 employees working in the province of Ontario is an OMERS member. Through the OMERS Worldwide brand, our team of investment professionals uses a direct drive, active management investment strategy to invest in public and private market assets, including publicly-traded equities, fixed-income, infrastructure, private equity and real estate. For more information, please visit: www.omers.com or www.omersworldwide.com.
CENTOGENE, founded in 2006, is a worldwide leader in the field of genetic diagnostics for rare hereditary diseases - with the largest test portfolio worldwide. Receiving samples from over 90 different countries allows Centogenea unique insight into epidemiological genetic differences, which is crucial in the medical result interpretation process.
The company is strictly focussing on offering quality molecular genetic diagnostics, underlined by our multiple international accreditations (ISO, CAP, CLIA).
Centogene's in depth medical expertise is supported by the application of cutting-edge technologies including next generation sequencing, whole exome sequencing (CentoXome®), whole genome sequencing and innovative biomarkers for selected diseases.
Centogene has developed a comprehensive mutation database (CentoMD®) that is pillar to offering high quality diagnostic reporting and medical interpretation, thoroughly interpret each patient's sequence data.
Beside diagnostic services for individual patients, Centogene is also a pivotal partner to multiple renown industrial partners worldwide.
Communications Manager, LifeLabs
416-675-4530 ext 2015
Tuesday, 04 February 2014 18:34
Panorama™ Non-Invasive Prenatal Test (NIPT) screens for common chromosome problems like Down syndrome by analyzing fetal DNA in a maternal blood sample. The Society of Obstetricians and Gynaecologists of Canada (SOGC) has recommended that NIPT be offered to women at increased risk of a fetal chromosome problem.
Panorama™ is one of the most affordable NIPTs in Canada.
The cost is $795 for detection of trisomy 21, 18, 13, monosomy X, and tripoidy/vanishing twin (gender is optional and available at no added cost).
Panorama™ is the only NIPT that can detect triploidy, and this is now provided at no additional cost.
Panorama™ NIPT is:
- Comprehensive - detection of trisomy 21, 18, 13, monosomy X, and triploidy/vanishing twin
- Simple and safe - standard maternal blood draw
- Timely - as early as 9 weeks gestation
- Accurate - >99% sensitivity for trisomy 21, 18, and 13 (and <0.1% false positive rate)
Who Is This Test For?
Leading professional associations such as the American College of Obstetricians and Gynecologists (ACOG) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) have recommended that NIPT be offered to women at increased risk of abnormal fetal chromosomal copy number.
Indications of an increased risk include:
- ≥35 years of age at delivery
- an abnormal prenatal serum screen
- personal history of a chromosome anomaly
- history of a previous pregnancy with a trisomy
- ultrasound finding suggestive of fetal aneuploidy
Although highly accurate, it is recommended that positive NIPT results be confirmed by diagnostic testing like chorionic villus sampling or amniocentesis.
When Should Panorama™ NOT Be Used:
- twins or multiple gestations
- egg donor or surrogate
- previous bone marrow transplant
Ordering Panorama™ is easy:
- Physician completes and signs the Panorama™ laboratory requisition form and retains the signed patient consent form – BC Requisition Form | Consent Form
- Patient calls LifeLabs at 1-855-412-4495 or BC Biomedical at 1-877-507-5595 to arrange an appointment for a blood draw at a convenient LifeLabs or BC Biomedical location
- The result is sent to the ordering physician within 10 days of blood draw (Note: results may take up to 14 days when the blood sample is drawn on a Friday due to shipping restrictions on weekends).
- LifeLabs will contact the ordering physician by telephone in the event of an abnormal result.
Visit our Panorama™ NIPT page to learn more.
Thursday, 16 January 2014 23:35
All BC Biomedical Laboratories locations will be closed Monday, February 10, 2014 for the Family Day holiday.
Tuesday, 12 November 2013 21:50
The Medical Services Commission has recently mandated changes to the Standard Outpatient Laboratory Requisition (SOPLR) specific to FIT testing. These changes can be found in the “Other Tests” section of the requisition.
To view an electronic copy of the requisition, please click here
To view a fillable printable copy, click here
Friday, 05 July 2013 22:42
LifeLabs and BC Biomedical are pleased to announce laboratory collection and testing services to Naturopathic Doctors of British Columbia.
- Over 100 Patient Service Locations across British Columbia. Some locations are open Saturday and Sunday for your patients’ convenience. Visit our LifeLabs and BC Biomedical websites to find the location closest to you.
- Over 1000 routine and specialized tests.
- Access to wellness, disease specific and gender tailored test panels.
- Electronic reporting. Access test results electronically, most within 24 hours of the sample collection.
- Kit collection service. We can help you facilitate sample collection for testing offered by out-of-country laboratory service providers.
To register for your account please complete the registration form.
Information Update – July 12, 2013
We have received an extraordinary amount of response to the announcement of our new service to Naturopathic Doctors. Thank you to all of you who expressed interest and submitted your registration form. We are currently processing a large number of applications so you may experience a small delay in having your account set up. We thank you for your patience.
In the meantime, here is some additional information that you may find useful.
Frequently Asked Questions
Are any of the tests billable to MSP?
No, the tests are not covered by the provincial medical service plan (MSP).
Could I see the price list before registering?
For confidentiality purposes, we are only able to share the fee schedule with our registered clients.
How is this service different from the arrangement with Rocky Mountain Analytical (RMA)?
RMA is a client of LifeLabs. The Naturopathic Doctors who submit RMA requisition forms will have their orders processed as per their signed service agreement with RMA. They will not be able to benefit from our faster turnaround time, free Excelleris electronic results reporting and competitive pricing. In order to have the tests processed under the LifeLabs service agreement, the clients will have to use LifeLabs requisition forms.
If I already order tests through LifeLabs, do I have to fill out a registration form?
Yes. Your account is with Rocky Mountain Analytical and in order to serve you directly, we need to have you register with us. Upon registration, you will be provided with separate requisition forms, electronic reporting information, and other elements unique to our service offering.
May I use both RMA and LifeLabs?
Yes, although you will likely find that going through LifeLabs directly will provide you with added service benefits.
If I am already a client of BC Biomedical, do I have to register again?
No. In April 2013, LifeLabs purchased BC Biomedical. Naturopathic Doctors who were BC Biomedical clients can now also use LifeLabs Patient Service Centers.
Please contact us by phone at 604-412-4421 should you require additional information.
Tuesday, 25 June 2013 17:49
TORONTO, June 25, 2013 – LifeLabs Medical Laboratory Services (“LifeLabs”), a leading Canadian provider of community laboratory services, announced today that it has entered into an Arrangement Agreement (the “Agreement”) with CML HealthCare Inc. (“CML”) under which LifeLabs will acquire all of the issued and outstanding common shares of CML for $10.75 per share in cash by way of a Plan of Arrangement.
The combination of LifeLabs with CML will expand community lab testing services for patients in the province of Ontario. LifeLabs and CML provide laboratory testing services that help Ontario health care providers diagnose, treat, monitor and prevent disease in patients. The two organizations provide high quality diagnostic services to community patients through patient service centers, homecare and long-term care facilities visits, and dedicated laboratory testing facilities. LifeLabs is indirectly owned by OMERS Administration Corporation, whose interest is managed by Borealis Infrastructure.
“I’m very pleased to announce that our two laboratory diagnostic companies are coming together in Ontario to serve patients and their health providers,” said Sue Paish, President and CEO of LifeLabs. “Coming together, we can be even stronger partners with government and health care providers in the planning and delivery of high quality and accessible diagnostic services for Canadians.”
“We see an exciting future for this business” said Michael Rolland, President and CEO of Borealis Infrastructure. “We welcome the talented staff at CML Healthcare to LifeLabs and look forward to the team working together to continue to lead the industry in the delivery of quality laboratory services that support the healthcare needs of Canadians.”
“Since 1971, CML has been a trusted partner of medical professionals, providing timely and accurate medical diagnostic testing services to Canadians,” said Patrice E. Merrin, Chairman of the CML Board of Directors. “LifeLabs, too, has an outstanding reputation of delivering quality care and I am confident that the combined organization will maintain and grow our trusted partner relationships. This is a natural fit for two strong companies.”
“Our two organizations care about patients and helping physicians identify the right course of action for better health care outcomes,” said Thomas Wellner, President and CEO of CML HealthCare. “So, in bringing the two companies together, we are fully aligned in our commitment to quality and continuous improvement in patient services in Ontario going forward. We are committed to transitioning seamlessly through our integration with LifeLabs, with a focus on operational excellence and providing the same level of quality service our customers and partners have come to expect.”
RBC Capital Markets is acting as financial advisor to Borealis Infrastructure and LifeLabs, and Blake, Cassels & Graydon LLP is acting as their legal advisor.
The Arrangement, which has been approved by the boards of directors of CML, LifeLabs and OMERS, is subject to approval by shareholders of CML at a Special Meeting to be held on September 3, 2013. The transaction is also subject to receipt of regulatory approvals and other customary closing conditions, including court approval. The transaction is expected to close in September of 2013.
LifeLabs is a Canadian-owned company and is the country’s largest provider of community laboratory services in the delivery of more than 50 million laboratory tests, serving over 11 million patients and 26,000 health care providers. For more information, visit: www.lifelabs.com.
For more information, please contact:
Tel: 416-675-4530 X2880 / Cell: 416-885-0842
About Borealis Infrastructure Management Inc.
Borealis Infrastructure is a leader in direct infrastructure investing with over a decade of investment experience and almost $20 billion in capital under management. Borealis invests in and manages a diversified portfolio of large-scale infrastructure assets exhibiting stability and strong cash flows, in sectors including energy, transportation and government-regulated services. It has offices in Toronto, London and New York. Borealis is the infrastructure investment arm of the OMERS Worldwide group of companies. More information can be found on www.borealis.ca
OMERS is one of Canada's largest pension funds with over $60 billion in net assets. It provides first-class pension administration and innovative products and services to over 400,000 members. Approximately one in every 20 employees working in the province of Ontario is an OMERS member. Through the OMERS Worldwide brand, our team of investment professionals uses a direct drive, active management investment strategy to invest in public and private market assets, including publicly-traded equities, fixed-income, infrastructure, private equity and real estate. For more information, please visit www.omers.com or www.omersworldwide.com.
CML serves more than 6 million patients each year at its more than 200 lab and diagnostic imaging sites in Ontario and British Columbia, processing over 40 million tests annually. The Company has been providing laboratory diagnostic services for more than 40 years in Ontario and is a publicly traded company. For more information, visit: www.cmlhealthcare.com
Monday, 24 June 2013 00:00
For more information about the LifeLabs privacy incident in Kamloops, please click here.
Saturday, 01 June 2013 00:00
As of June 1st, MSP will be making changes to their coverage of 25-Hydroxy-Vitamin-D testing. After June 1st this test will be covered by MSP when ordered by a Specialist or for patients younger than 19 years of age. In all other scenarios, this test will be available at LifeLabs and BC Biomedical on a patient pay basis.
Wednesday, 24 April 2013 23:33
April 28 – May 4, 2013
National Medical Laboratory Week is an annual event that promotes awareness and understanding of the role of medical laboratory professionals in the health care system. Patient care is supported by medical laboratory professionals.
Click here to find out more
Wednesday, 24 April 2013 00:00
BC Biomedical Laboratories celebrated the grand opening of our Fleetwood Patient Service Centre on April 24. This new location, located on the corner of 152 and Fraser Highway is easily accessible and has the convenience of lots of free parking.
Tuesday, 02 April 2013 18:53
TORONTO, ONTARIO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 2, 2013) - LifeLabs Medical Laboratory Services ("LifeLabs") today announced it has completed the purchase of BC Biomedical Laboratories Ltd. ("BC Biomedical") following approvals from the Federal Competition Bureau and the Provincial government. The two companies are coming together to better serve BC patients and their health providers.
Tuesday, 02 April 2013 14:51
On April 1, 2013, fecal immunochemical testing (FIT) will be available as an MSP billable test. When checking the fecal occult blood box on the laboratory requisition FIT testing will be performed.
The standard guaiac fecal occult blood test, funded by MSP, is available upon request. In addition BC Biomedical will test using the guaiac method when an order of “occult blood x2” or “occult blood x3” is handwritten on the requisition under the Other Tests section.
Tuesday, 15 January 2013 22:46
TORONTO, ONTARIO / VANCOUVER, BRITISH COLUMBIA (January 15, 2013) - LifeLabs Medical Laboratory Services (“LifeLabs”) today announced it has entered into an agreement to purchase B.C. Biomedical Laboratories Ltd. (“BC Biomedical”) to better serve patients in the province of British Columbia. LifeLabs and BC Biomedical provide laboratory testing services that help B.C. health care providers diagnose, treat, monitor and prevent disease in patients. The two organizations provide high quality diagnostic services to community patients through patient service centers, homecare and long-term care visits, and dedicated laboratory testing facilities.
Thursday, 15 November 2012 16:43
We have recently created a Microbiology visual aid for physicians. This aid shows the Microbiology Swab & Collection Container Requirements for swabsand containers distributed by BC Biomedical.
- BC Biomedical marks 12th Consecutive Year as a Best Employer
- Grand Opening of Surrey Central Patient Service Centre
- SHS Patient Service Centre Move
- Grand Opening of Sapperton Patient Service Centre
- Sapperton Patient Service Centre Move
- Latest Laboratory Requisition Now Available
- City Square Location Now Open Saturdays
- 2012 Antibiogram
- BC Biomedical Laboratories named one of the 30 Greenest Employers in Canada for 3rd year
- Medical Lab Assistants - Now Hiring!
Page 1 of 4«StartPrev1234NextEnd»